Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2022
Polyphenols as the Potential Disease-modifying Therapy in CancerVladimir Rogovskii
Current Cancer Drug Targets|January 30, 2024
Cancer and Autoimmune Diseases as Two Sides of Chronic Inflammation and the Method of TherapyVladimir Rogovskii
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 24, 2019
Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell FunctionsMikhail Melnikov, Vladimir Rogovskii, Alexey Boykо, et al.
Multiple Sclerosis and Related Disorders|February 18, 2018
The influence of biogenic amines on Th17-mediated immune response in multiple sclerosisMikhail Melnikov, Vladimir Rogovskii, Alexey Boyko, et al.
Journal of Neuroimmunology|May 17, 2021
The role of 5-HT<sub>2B</sub>-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosisAnastasiya Sviridova, Vladimir Rogovskii, Vladimir Kudrin, et al.
Pharmaceutics|May 27, 2026
Anti-Inflammatory Properties of Curcumin as Add-On Therapy in Patients with MS-Prospective, Comparative, Randomized, Pilot StudyAnna Kukushkina, Vladimir Rogovskii, Olga Zhilenkova, et al.
International Journal of Molecular Sciences|January 21, 2022
The Dual Role of the β<sub>2</sub>-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple SclerosisMikhail Melnikov, Vladimir Rogovskii, Anastasiya Sviridova, et al.
Current Neuropharmacology|August 25, 2021
The Role of D<sub>2</sub>-like Dopaminergic Receptor in Dopamine-mediated Modulation of Th17-cells in Multiple SclerosisMikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, et al.
Frontiers in Pharmacology|January 24, 2025
Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancerVladimir Rogovskii, Vladimir V Murugin, Nikolay Vorobyev, et al.
Multiple Sclerosis and Related Disorders|March 23, 2021
Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapyMikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, et al.
Pageof 2